Abstract Body

Background

Access to HIV pre-exposure prophylaxis (PrEP) has expanded significantly in resource-limited settings, including Mozambique, where oral PrEP was implemented at select health facilities in 2017, and nationally in 2021. Understanding patterns of oral PrEP uptake and persistence is essential to inform relevant strategies.

Methods

We conducted a mixed-methods evaluation to assess uptake and continuation on oral PrEP among population at risk of HIV acquisition across 22 health facilities in four provinces (Maputo City, Manica, Nampula, and Zambézia).  Uptake was defined as the proportion of eligible individuals who initiated PrEP. Continuation was defined as uninterrupted use or with a gap ≤90 days, assessed at 6, 9 and 12 months post-initiation. We analyzed routine program data collected from individuals who initiated on oral PrEP October 2021 to March 2023. Descriptive statistics included proportions, medians, and interquartile ranges (IQR); comparisons used Chi-square, Kruskal-Wallis, or t-tests.

Results

Of 10,513 HIV-negative persons offered PrEP, uptake was high at 98.6% (n=10,364). The median age was 23 years and 66.1% were between 15-24 years old. The cohort included 4,105 (39.6%) adolescent and young people (AYP), 1,588 (15.3%) pregnant women (PW), 478 (4.6%) breast-feeding women (BFW), 3,188 (30.8%) women engaged in sex work (WCS), and 1,005 (9.7%) men who have sex with men (MSM). Of those initiated, 4,706 (45.4%), 3,028 (29.2%), and 1,518 (14.6%) completed 6, 9, and 12 months observation, respectively. While PrEP initiation was high, continued attendance at scheduled pill pickup visits declined over time: only 5.4% (556/10,364) attended all four scheduled pill pickups; 9.1% (945) attended three visits, 22.8% (2,365) attended two, and 62.7% (6,498) attended only one pickup visit. Oral PrEP continuation at six months post-PrEP initiation was 39.8% (1,871/4,706) with significant variation by population group: PW (49.3%), WCS (49.0%), MSM (38.2%), AYP (31.7%), and BFW (30.5%), (p<0.001). Continuation decreased to 22.0% (665/3,028) at nine and 7.2% (110/1,518) at 12 months.

Conclusions

In this large cohort in Mozambique, there was high uptake of oral PrEP in routine clinical settings, however, overall PrEP continuation was low and decreased over time, with substantial variation by population. Long-acting PrEP options offer the opportunity to enhance perseverance on PrEP, reducing the risk of HIV acquisition.